• Five Steps to Commercialization Success and Common Challenges You Can Easily Avoid

    Bio-IT World Contributed Commentary | It’s no surprise that advancements in novel technologies and the advent of big data have propelled significant breakthroughs in pharmaceutical development. The last decade has not only seen an increase in new chemical and biological entities but also significantly more innovative medicines reaching the market. Looking to the future, we also expect to see an intensified focus on neglected diseases as new and emerging biopharma companies (EBP) drive new medicine launches. However, to get there, organizations reaching for “first-in-market” status or securing key market areas depends on their ability to swiftly commercialize these new technologies and therapeutics.

    Aug 17, 2020

  • New Computational Tool from St. Jude Tackles ‘The Other 98%’ of Human Genome

    Bio-IT World | St. Jude Children's Research Hospital scientists have developed a computational tool to identify cancer-causing mutations lurking in the vast and largely unexplored regions of the human genome.

    Aug 13, 2020

  • NIH Launches Data Science for Health Discovery and Innovation in Africa Grant Program

    Bio-IT World In a virtual symposium this week—rescheduled from a live event in Uganda—the National Institutes of Health launched a new program: Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa). The program will leverage data science technologies and prior NIH investments to develop solutions to the continent’s most pressing public health problems through a robust ecosystem of new partners from academic, government, and private sectors.

    Aug 12, 2020

  • Learning the Language of Data Science and Pushing Science Forward

    Bio-IT World | In our current COVID-19 reality, the NIH’s Associate Director for Data Science sees an opportunity for a leap forward in our thinking about data sharing.

    Aug 11, 2020

  • Successful Data Migration Projects Take Planning

    Bio-IT World Contributed Commentary | Given all the merger and divestiture activity among companies, there will always be a need to move data from one system to another. Proper planning and user feedback are just a few ways to ensure a successful migration project.

    Aug 10, 2020

  • Researchers Using Models To Understand COVID-19, Other News

    Bio-IT World | Researchers are continuing to analyze COVID-19 through several models. A new mouse model is being developed in China to test and confirm the efficacy of a potential vaccine, while a researcher in the US is using computer models to understand the structure of the virus.

    Aug 7, 2020

  • Time to Innovate for Faster, Smarter Discovery and Clinical Development Cycles

    Bio-IT World Contributed Commentary | We’ve learned so much living through these unprecedented times. One lesson is the need to mobilize quickly, provide effective testing and contact tracing, and accelerate the development of therapies and vaccines to protect the global community. That can only be done through the power of data: the defining currency in drug discovery and clinical development.

    Aug 6, 2020

  • Follow the Money: Cash for AI Models, Oncology, Hematology Therapies

    Bio-IT World  Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. Glioblastoma, hematology, and acute pancreatitis all see new funding for therapy development. And AI-powered models net cash.

    Aug 5, 2020

  • Ancestry Launches NGS Tests With Family History Component

    Bio-IT World | Ancestry has launched AncestryHealth powered by Next Generation Sequencing. It is an upgrade to AncestryDNA + Traits, adding genetic health risk reports, a family health history tool, and other resources.

    Aug 4, 2020

  • One Small Step For Open Science, One Giant Leap For Metastasis Research

    Bio-IT World | In a first-of-its-kind collaboration, researchers from 19 academically affiliated international laboratories have agreed to share their cell line models specific to brain metastasis with pretty much anyone who asks for them.

    Aug 3, 2020

  • New Data on Genetic Expression In Severe COVID-19, Pre-Existing Immune Response

    Bio-IT World | Research continues to uncover the underlying biology of SARS-CoV-2 and reveal some surprises. A German team found that 35% of their healthy controls had pre-existing SARS-CoV-2 cross-reactive T cells, and several groups are narrowing down the gene expression signatures that might explain why COVID-19 is so severe in some patients.

    Jul 31, 2020

  • Celsius Therapeutics, Twist Bioscience, And More: News From July 2020

    Bio-IT World July featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Celsius Therapeutics, Twist Bioscience, and more.

    Jul 30, 2020

  • Coronavirus Exposure Could Induce Long-Lasting Memory T Cells, Other COVID-19 News

    Bio-IT World | A new collaborative study suggests that infection and exposure to coronaviruses induces long-lasting memory T cells, which could help in the management of the current pandemic and in vaccine development against COVID-19. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

    Jul 24, 2020

  • Cell, Gene Therapy Manufacturing As Large-Scale Biology

    Bio-IT World Contributed Commentary | The last three years we have witnessed an exponential expansion of the cell and gene therapy space, both in the number of cell and gene therapies approved or in development, and the real and projected values of the market. This growth is rapidly changing the way we think about what medicines are.

    Jul 23, 2020

  • PacBio’s Focus on Human Genomics And Read Length Sweet Spot

    Bio-IT World | It seems like a very long time ago, now, that Illumina and Pacific Biosciences dissolved their merger agreement, but in fact their announcement is just about six months old. Since then, PacBio has been busy reestablishing itself as an independent business and looking ahead, their sights set on the human genome sequencing market.

    Jul 21, 2020

  • How Mass Spectrometry is Accelerating Quantitative Proteomics

    Bio-IT World Contributed Commentary | Mass spectrometry has transitioned from being used mostly in routine analytical applications to becoming a powerful biological method for protein quantitation.

    Jul 20, 2020

  • Populations With Unique Enzymes More Susceptible To COVID-19, Other News

    Bio-IT World | Researchers from Cleveland Clinic have found unique genetic susceptibility to COVID-19 across populations in ACE2 and TMPRSS2. Elsewhere, the University of California Health has developed a unified, secure data set for use in COVID-19 research. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

    Jul 16, 2020

  • In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age

    Bio-IT World | Duplex Sequencing, a technique for improving the accuracy of next-generation sequencing by more than 10,000-fold, could eliminate a good deal of the guesswork in advancing drugs to market.

    Jul 15, 2020

  • Breaking Silos to Enable Breakthroughs

    Bio-IT World | TRENDS FROM THE TRENCHES | For most big pharma and other global enterprises, decades of growth have resulted in siloed operations, even as they seek breakthrough medicines. It is time for such a breakthrough; as an industry, we’re overdue.

    Jul 14, 2020

  • Illumina Launches TruSight Software Suite, Accelerating Identification of Genetic Diseases

    Bio-IT World News Brief | Illumina, in collaboration with Mayo Clinic and other key opinion leaders, has launched its TruSight Software Suite in an effort to bring turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing.

    Jul 10, 2020